BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 28397728)

  • 1. Recommendations on the Clinical Use of Compound Danshen Dripping Pills.
    Writing Group of Recommendations of Expert Panel from Chinese Geriatrics Society on the Clinical Use of Compound Danshen Dripping Pills
    Chin Med J (Engl); 2017 Apr; 130(8):972-978. PubMed ID: 28397728
    [No Abstract]   [Full Text] [Related]  

  • 2. Systematic review and meta-analysis of randomized controlled trials comparing compound danshen dripping pills and isosorbide dinitrate in treating angina pectoris.
    Yao Y; Feng Y; Lin W
    Int J Cardiol; 2015 Mar; 182():46-7. PubMed ID: 25585358
    [No Abstract]   [Full Text] [Related]  

  • 3. Compound Danshen dripping pills in treating with coronary heart disease: A protocol for systematic review and meta-analysis.
    Sun L; Zhang YN
    Medicine (Baltimore); 2022 Feb; 101(7):e28927. PubMed ID: 35363219
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of Guanxin Danshen Dripping Pills on Coronary Heart Disease Comorbid with Depression or Anxiety: The ADECODE-Real World Study.
    Wu SH; Shi WQ; Li YH; Liu RH; Hu DY; Zheng LQ; Ma WL
    Chin J Integr Med; 2024 May; 30(5):443-448. PubMed ID: 37947990
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of Compound Danshen Dripping Pills combined with western medicine in the treatment of diabetic retinopathy: a systematic review and meta-analysis of randomized controlled trials.
    Huang H; Li Y; Huang Q; Lei R; Zou W; Zheng Y
    Ann Palliat Med; 2021 Oct; 10(10):10954-10962. PubMed ID: 34763458
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical study of guanxin danshen dropping pills combined with meglumine cyclophosphate in the treatment of angina pectoris in elderly patients with coronary heart disease.
    Yu C; Zhang Y; Liu X
    Panminerva Med; 2023 Dec; 65(4):549-551. PubMed ID: 34544224
    [No Abstract]   [Full Text] [Related]  

  • 7. [Clinical study of diabetic retinopathy treated by compound danshen dripping pills].
    Qi CX; Tan XH; Li QG; Wang XL
    Zhong Yao Cai; 2007 Mar; 30(3):375-7. PubMed ID: 17634050
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effectiveness and safety of a danshen-containing Chinese herbal medicine for diabetic retinopathy: a randomized, double-blind, placebo-controlled multicenter clinical trial.
    Lian F; Wu L; Tian J; Jin M; Zhou S; Zhao M; Wei L; Zheng Y; Wang Y; Zhang M; Qin W; Wu Z; Yuan CS; Tong X
    J Ethnopharmacol; 2015 Apr; 164():71-7. PubMed ID: 25666427
    [TBL] [Abstract][Full Text] [Related]  

  • 9. LC-MS-based metabolomics reveals metabolic changes in short- and long-term administration of Compound Danshen Dripping Pills against acute myocardial infarction in rats.
    Zhang L; Wang LL; Zeng H; Li B; Yang H; Wang GJ; Li P
    Phytomedicine; 2022 Sep; 104():154269. PubMed ID: 35717805
    [TBL] [Abstract][Full Text] [Related]  

  • 10. How Efficacious is Danshen (Salvia miltiorrhiza) Dripping Pill in Treating Angina Pectoris? Evidence Assessment for Meta-Analysis of Randomized Controlled Trials.
    Jia Y; Leung SW
    J Altern Complement Med; 2017 Sep; 23(9):676-684. PubMed ID: 28650203
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Compound salvia pellet, a traditional Chinese medicine, for the treatment of chronic stable angina pectoris compared with nitrates: a meta-analysis.
    Wang G; Wang L; Xiong ZY; Mao B; Li TQ
    Med Sci Monit; 2006 Jan; 12(1):SR1-7. PubMed ID: 16369479
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Compound Danshen Dripping Pill ameliorates post ischemic myocardial inflammation through synergistically regulating MAPK, PI3K/AKT and PPAR signaling pathways.
    Lei W; Li X; Li L; Huang M; Cao Y; Sun X; Jiang M; Zhang B; Zhang H
    J Ethnopharmacol; 2021 Dec; 281():114438. PubMed ID: 34390798
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Research of the dynamic regulatory mechanism of Compound Danshen Dripping Pills on myocardial infarction based on metabolic trajectory analysis.
    Zhang CJ; Qu XY; Yu ZY; Yang J; Zhu B; Zhong LY; Sun J; He JH; Zhu YX; Dong L; Xu WJ
    Phytomedicine; 2024 Jul; 130():155626. PubMed ID: 38850631
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Is danshen (Salvia miltiorrhiza) dripping pill more effective than isosorbide dinitrate in treating angina pectoris? A systematic review of randomized controlled trials.
    Jia Y; Huang F; Zhang S; Leung SW
    Int J Cardiol; 2012 Jun; 157(3):330-40. PubMed ID: 21251721
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of compound Danshen dropping pills on adverse cardiovascular events and quality of life after percutaneous coronary intervention in patients with coronary heart disease: A protocol for systematic review and meta-analysis.
    Lv L; Yuan X; Jiang L
    Medicine (Baltimore); 2022 Feb; 101(8):e28994. PubMed ID: 35212312
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Study of the protective mechanisms of Compound Danshen Tablet (Fufang Danshen Pian) against myocardial ischemia/reperfusion injury via the Akt-eNOS signaling pathway in rats.
    Ren-an Q; Juan L; Chuyuan L; Wenjuan F; Chunyan H; Xuemei Y; Lin H; Hong N
    J Ethnopharmacol; 2014 Oct; 156():190-8. PubMed ID: 25178948
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Chinese patent medicine Salvia miltiorrhiza depside salts for infusion combined with conventional treatment for patients with angina pectoris: A systematic review and meta-analysis of randomized controlled trials.
    Zhang Y; Xie Y; Liao X; Jia Q; Chai Y
    Phytomedicine; 2017 Feb; 25():100-117. PubMed ID: 28190464
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Salvia miltiorrhiza and ischemic diseases.
    Ji XY; Tan BK; Zhu YZ
    Acta Pharmacol Sin; 2000 Dec; 21(12):1089-94. PubMed ID: 11603281
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proangiogenesis effects of compound danshen dripping pills in zebrafish.
    Hu YX; You HM; Ren CZ; Hu BW; Zhang LJ; Zhang YD; He ZQ; Ding R; Guo ZF; Liang C
    BMC Complement Med Ther; 2022 Apr; 22(1):112. PubMed ID: 35459153
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development and Evaluation of Controlled and Simultaneous Release of Compound Danshen Based on a Novel Colon-Specific Osmotic Pump Capsule.
    Nie X; Wang B; Hu R; Lu W; Chen J; Liu S; Jin D; Sun C; Gao S; Guo Y; Fang W; Hao H
    AAPS PharmSciTech; 2020 Jan; 21(2):38. PubMed ID: 31897797
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.